**Core Concept**
Pirenzepine is a selective M1 muscarinic receptor antagonist, which means it specifically blocks the action of acetylcholine at the M1 subtype of muscarinic receptors in the parasympathetic nervous system. This receptor subtype is primarily found in the central nervous system, including the brain, and is involved in various physiological processes.

**Why the Correct Answer is Right**
Pirenzepine acts by competitively inhibiting the binding of acetylcholine to M1 muscarinic receptors. This results in decreased parasympathetic tone, leading to decreased salivation, gastric acid secretion, and bronchial secretions. The M1 muscarinic receptors are also involved in the regulation of smooth muscle contraction and the modulation of neurotransmitter release in the central nervous system.

**Why Each Wrong Option is Incorrect**
**Option A:** Muscarinic receptors have three subtypes: M1, M2, and M3. Pirenzepine is selective for M1 receptors, but it does not act on M2 or M3 receptors. M2 receptors are primarily involved in the regulation of heart rate, while M3 receptors are involved in smooth muscle contraction and glandular secretion.

**Option B:** Pirenzepine is a muscarinic receptor antagonist, but it is not a nicotinic receptor antagonist. Nicotinic receptors are involved in the regulation of the autonomic nervous system and are responsible for the effects of nicotine.

**Option C:** Pirenzepine is a selective M1 muscarinic receptor antagonist, but it is not a dopamine receptor antagonist. Dopamine receptors are involved in various physiological processes, including motor control, motivation, and reward.

**Option D:** Pirenzepine is a muscarinic receptor antagonist, but it is not a serotonin receptor antagonist. Serotonin receptors are involved in various physiological processes, including mood regulation, appetite, and sleep.

**Clinical Pearl / High-Yield Fact**
Pirenzepine is used clinically to treat peptic ulcers and gastroesophageal reflux disease (GERD) by reducing gastric acid secretion. It is also being investigated for its potential use in the treatment of cognitive impairment and Alzheimer's disease.

**Correct Answer: C. M1 muscarinic receptor.**